News | February 11, 2015

Zoll AutoPulse Non-Invasive Cardiac Support Pump Achieves 75 Percent ROSC Rate in Patients During the First Three Weeks

RAV Gelderland-Midden equipped fleet of ambulances with product

Sudden cardiac arrest, resuscitation devices, AutoPulse, ZOLL

Image courtesy of Zoll

February 11, 2015 — Zoll Medical Corporation, a manufacturer of medical devices and related software solutions, announced that RAV Gelderland-Midden in the Netherlands has equipped its fleet of 20 ambulances with the Zoll AutoPulse Non-invasive Cardiac Support Pump.

During the first three weeks of implementation, RAV Gelderland-Midden treated 20 patients for sudden cardiac arrest, with 15 of them experiencing return of spontaneous circulation (ROSC).

According to Arjan de Kreek, the nurse practitioner of emergency medical care who headed the project, RAV Gelderland-Midden studied all the clinical literature on mechanical CPR devices and found that only the AutoPulse has shown to have clinical benefits in comparative human trials.

“RAV Gelderland-Midden works in close harmony with surrounding hospitals in cities such as Arnhem, Nijmegen and Ede. All of our counterparts use the AutoPulse,” de Kreek explained. “The AutoPulse in this region is used by first responders, ambulances, emergency departments and cath labs.”

De Kreek developed a training video on the AutoPulse that is used by all paramedics and the fire department. The video, along with hands-on training and the e-learning module ZOLL provides, instructs emergency personnel on how to use the device.

For RAV Gelderland-Midden, the flat design of the AutoPulse makes it possible to store the units aboard the agency’s Sprinter rescue vehicles in an ergonomic way. Paramedics can carry the AutoPulse as a backpack.

“In addition to rapid deployment with the AutoPulse, running a code with just two paramedics would not be a problem, since the device gives compressions, allowing the rescuers to take care of other interventions,” said paramedic Roy Rosmulder.

The AutoPulse is the only mechanical CPR system to have shown improved outcomes in comparative clinical trials. In a meta-analysis of 12 comparative clinical trials, the AutoPulse improved the odds of return of spontaneous circulation (ROSC) by 62% compared to manual CPR. The CIRC trial, the largest prospective, randomized trial of mechanical chest compression ever completed, confirmed that the AutoPulse is equivalent to high-quality manual CPR for survival to hospital discharge.

For more information: www.zoll.com

 

 

 

Related Content

Health Insurance Expansion Linked to Fewer Sudden Cardiac Arrests
News | Sudden Cardiac Arrest| July 11, 2017
The incidence of sudden cardiac arrest, an often deadly loss of heart function, declined significantly among previously...
European Heart Rhythm Association Launches Cardiac Arrest First Responder App
News | Mobile Devices| June 30, 2017
A novel smartphone application has been developed that can direct first responders to cardiac arrest victims more than...
Cedars-Sinai Team Develops New Sudden Cardiac Arrest Risk Assessment Score
News | Sudden Cardiac Arrest| June 26, 2017
A Cedars-Sinai Heart Institute investigator and his team have developed a new risk assessment tool that brings...
wearable defibrillators prevent sudden cardiac death in pediatric patients
Feature | Sudden Cardiac Arrest| May 11, 2017
May 11, 2017 — A new study shows that the use of a wearable cardioverter defibrillator (WCD) is safe and effective in
AEDs, automated external defibrillators, requirements, U.S. schools, JACC study
News | Defibrillator Monitors| March 30, 2017
Automated external defibrillators (AEDs) are associated with increased survival of sudden cardiac arrest when installed...
genetic testing, sudden cardiac death of teen, Mayo Clinic Proceedings
News | Genetic Testing| November 09, 2016
The recent, sudden death of a 13-year-old boy resulted in more than 20 relatives being incorrectly diagnosed as having...
Sponsored Content | Videos | Sudden Cardiac Arrest| October 28, 2016
This video, provided by Zoll, demonstrates how cardiologists can explain sudden cardiac death to patients.
LifePak, AED, sudden cardiac arrest, defibrillator, automatic external defibrillator

A Physio-Control LifePak CR Plus defibrillator shown in use during a hand-off to paramedics, who use larger, more sophisticated defibrillator-monitors (behind gloved paramedic).

Feature | Sudden Cardiac Arrest| September 28, 2016 | Allied Market Research
Automated external defibrillators (AED) are portable and lightweight devices used to deliver an electric shock throug
sudden cardiac arrest, out-of-hospital, comatose patients, University of Arizona study, wake up
News | Sudden Cardiac Arrest| July 13, 2016
Physicians may be drawing conclusions too soon about survival outcomes of patients who suffered a cardiac arrest...
Overlay Init